Vanguard Group Inc Pliant Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,334,575 shares of PLRX stock, worth $5.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,334,575
Previous 3,228,755 3.28%
Holding current value
$5.77 Million
Previous $42.5 Million 89.41%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$1.35 - $13.53 $142,857 - $1.43 Million
105,820 Added 3.28%
3,334,575 $4.5 Million
Q4 2024

Feb 11, 2025
SELL
$10.55 - $15.7 $3.14 Million - $4.67 Million
-297,759 Reduced 8.44%
3,228,755 $42.5 Million
Q3 2024

Nov 13, 2024
BUY
$10.52 - $14.35 $940,004 - $1.28 Million
89,354 Added 2.6%
3,526,514 $39.5 Million
Q2 2024

Aug 13, 2024
SELL
$10.58 - $15.61 $435,843 - $643,053
-41,195 Reduced 1.18%
3,437,160 $36.9 Million
Q1 2024

May 10, 2024
BUY
$14.14 - $19.59 $5.83 Million - $8.08 Million
412,486 Added 13.45%
3,478,355 $51.8 Million
Q4 2023

Feb 14, 2024
BUY
$12.85 - $19.15 $1.55 Million - $2.31 Million
120,557 Added 4.09%
3,065,869 $55.5 Million
Q3 2023

Nov 14, 2023
BUY
$14.58 - $20.15 $2.46 Million - $3.39 Million
168,454 Added 6.07%
2,945,312 $51.1 Million
Q2 2023

Aug 14, 2023
BUY
$18.12 - $30.56 $7.32 Million - $12.4 Million
404,136 Added 17.03%
2,776,858 $50.3 Million
Q1 2023

May 15, 2023
BUY
$18.73 - $36.26 $7.94 Million - $15.4 Million
423,678 Added 21.74%
2,372,722 $63.1 Million
Q4 2022

Feb 10, 2023
BUY
$17.0 - $25.43 $5.95 Million - $8.89 Million
349,720 Added 21.87%
1,949,044 $37.7 Million
Q3 2022

Nov 14, 2022
BUY
$7.67 - $24.23 $4.19 Million - $13.2 Million
546,638 Added 51.93%
1,599,324 $33.4 Million
Q2 2022

Aug 12, 2022
SELL
$4.11 - $8.75 $739,853 - $1.58 Million
-180,013 Reduced 14.6%
1,052,686 $8.43 Million
Q1 2022

May 13, 2022
BUY
$7.01 - $14.1 $100,165 - $201,474
14,289 Added 1.17%
1,232,699 $8.64 Million
Q4 2021

Feb 14, 2022
SELL
$12.27 - $18.26 $2.46 Million - $3.66 Million
-200,189 Reduced 14.11%
1,218,410 $16.4 Million
Q3 2021

Nov 12, 2021
BUY
$16.48 - $28.98 $2.42 Million - $4.26 Million
146,943 Added 11.56%
1,418,599 $23.9 Million
Q2 2021

Aug 13, 2021
BUY
$28.05 - $37.69 $35.7 Million - $47.9 Million
1,271,656 New
1,271,656 $37 Million

Others Institutions Holding PLRX

# of Institutions
154
Shares Held
62.4M
Call Options Held
279K
Put Options Held
7.1K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $84.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email